KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Accenture (ACN) EBT (2016 - 2026)

Accenture (ACN) has disclosed EBT for 17 consecutive years, with $2.1 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT fell 11.03% year-over-year to $2.1 billion, compared with a TTM value of $10.3 billion through Aug 2025, up 5.89%, and an annual FY2025 reading of $10.3 billion, up 5.89% over the prior year.
  • EBT was $2.1 billion for Q3 2025 at Accenture, down from $3.0 billion in the prior quarter.
  • Across five years, EBT topped out at $3.0 billion in Q4 2024 and bottomed at $1.8 billion in Q1 2021.
  • Average EBT over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2025.
  • The sharpest move saw EBT grew 24.59% in 2021, then decreased 12.73% in 2023.
  • Year by year, EBT stood at $2.4 billion in 2021, then increased by 8.12% to $2.6 billion in 2022, then rose by 0.58% to $2.6 billion in 2023, then grew by 12.94% to $3.0 billion in 2024, then fell by 29.78% to $2.1 billion in 2025.
  • Business Quant data shows EBT for ACN at $2.1 billion in Q3 2025, $3.0 billion in Q2 2025, and $2.3 billion in Q1 2025.